$XBIT News Article - XBiotech Announces French National Agency (ANSM) Approval and National Cancer Institute (INSA) funding to Support Phase I/II/III Clinical Study for Natrunix(TM) in Combination with Trifluridine/Tipiracil (TASKIN) for Treatment of Metastatic Colorectal Can
https://marketwirenews.com/news-releases/xbio...07400.html